American Society for Clinical Pharmacology and Therapeutics

American Society for Clinical Pharmacology and Therapeutics
Name	American Society for Clinical Pharmacology and Therapeutics
Abbreviation	ASCP
Formation	1900s
Type	Professional association
Headquarters	United States
Region served	North America
Leader title	President

Contents

American Society for Clinical Pharmacology and Therapeutics is a professional association focused on clinical pharmacology and therapeutics in the United States. The society brings together researchers from institutions such as National Institutes of Health, Food and Drug Administration, and Mayo Clinic alongside clinicians from Johns Hopkins Hospital and industry professionals from Pfizer and Merck & Co.. It fosters collaboration among members affiliated with universities like Harvard University, Stanford University, and University of California, San Francisco and engages with regulatory bodies including European Medicines Agency and World Health Organization. The society interfaces with professional organizations such as American Medical Association, Pharmaceutical Research and Manufacturers of America, and American Association of Pharmaceutical Scientists.

History

The society traces roots to early 20th-century gatherings that included participants from University of Pennsylvania, Columbia University, and Massachusetts General Hospital, paralleling developments at Rockefeller Institute and NIH Clinical Center. Over decades it interacted with landmark regulatory events involving the Food, Drug, and Cosmetic Act and personalities associated with Frances Kelsey and Harvey Cushing. In the late 20th century the society expanded during the eras of leaders from Johns Hopkins University and University of Chicago and collaborated on initiatives with American College of Clinical Pharmacy and British Pharmacological Society. Its evolution reflects scientific shifts linked to work by researchers at Oxford University, Cambridge University, and Karolinska Institutet.

The society’s mission aligns with goals pursued by National Academy of Medicine, Institute of Medicine, and Centers for Disease Control and Prevention to advance patient-centered pharmacotherapy. Objectives include promoting research originating in laboratories like Salk Institute and Cold Spring Harbor Laboratory, improving translational pipelines associated with Broad Institute and Dana-Farber Cancer Institute, and supporting regulatory science relevant to European Medicines Agency and Food and Drug Administration. The society seeks to bridge stakeholders from AstraZeneca, GlaxoSmithKline, and academic centers such as Yale School of Medicine and University of Michigan Medical School.

Programs include clinical trial methodology workshops similar to offerings by Duke Clinical Research Institute and training collaborations with Clinical and Translational Science Awards Program and European Clinical Research Infrastructure Network. The society runs mentorship initiatives that echo programs at Howard University, Morehouse School of Medicine, and University of Puerto Rico Medical Sciences Campus, and career development efforts aligned with National Institutes of Health grant mechanisms like K Award and R01 grant. It partners with consortia such as TransCelerate Biopharma and networks including Sentinel Initiative and Observational Health Data Sciences and Informatics.

The society sponsors peer-reviewed outlets in the tradition of journals like The New England Journal of Medicine, The Lancet, and Journal of the American Medical Association, and collaborates with publishers associated with Elsevier and Wiley-Blackwell. Its publication program features articles addressing translational science akin to work in Nature Medicine, Science Translational Medicine, and Clinical Pharmacology & Therapeutics style journals. Editorial boards include scholars affiliated with Stanford School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, and Imperial College London.

Annual meetings bring together delegates from American Society of Clinical Oncology, European Society for Clinical Nutrition and Metabolism, and representatives from World Congress of Pharmacology; locations have included venues in Boston, San Diego, and Chicago. Educational content often features keynote lectures by investigators from Cold Spring Harbor Laboratory, Salk Institute, and Harvard Medical School, and symposia co-organized with American Pharmacists Association and International Union of Basic and Clinical Pharmacology. The society provides continuing medical education credits recognized by Accreditation Council for Continuing Medical Education.

The society advocates on issues intersecting with Food and Drug Administration regulation, National Institutes of Health funding, and policies debated in United States Congress committees such as the Senate Committee on Health, Education, Labor and Pensions and House Committee on Energy and Commerce. It has submitted position statements comparable to interventions by American Medical Association and American Society of Health-System Pharmacists and collaborated on white papers with Institute for Clinical and Economic Review and Brookings Institution. Engagements include stakeholder dialogues with European Commission officials and international partnerships involving World Health Organization programs.

Category:Medical associations based in the United States